FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q104058579> ?p ?o ?g. }

• Q104058579 description "2020 nî lūn-bûn" @default.
• Q104058579 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 3ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
• Q104058579 description "2020年の論文" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年学术文章" @default.
• Q104058579 description "2020年學術文章" @default.
• Q104058579 description "2020年學術文章" @default.
• Q104058579 description "2020年學術文章" @default.
• Q104058579 description "2020年學術文章" @default.
• Q104058579 description "2020年學術文章" @default.
• Q104058579 description "2020년 논문" @default.
• Q104058579 description "article científic" @default.
• Q104058579 description "article scientific" @default.
• Q104058579 description "article scientifique" @default.
• Q104058579 description "articol științific" @default.
• Q104058579 description "articolo scientifico" @default.
• Q104058579 description "artigo científico" @default.
• Q104058579 description "artigo científico" @default.
• Q104058579 description "artigo científico" @default.
• Q104058579 description "artikel ilmiah" @default.
• Q104058579 description "artikull shkencor" @default.
• Q104058579 description "artikulong pang-agham" @default.
• Q104058579 description "artykuł naukowy" @default.
• Q104058579 description "artículo científico publicado en 2020" @default.
• Q104058579 description "artículu científicu" @default.
• Q104058579 description "bilimsel makale" @default.
• Q104058579 description "bài báo khoa học" @default.
• Q104058579 description "naučni članak" @default.
• Q104058579 description "scienca artikolo" @default.
• Q104058579 description "scientific article published on 03 December 2020" @default.
• Q104058579 description "scientific article published on 3 December 2020" @default.
• Q104058579 description "scientific article published on 3 December 2020" @default.
• Q104058579 description "teaduslik artikkel" @default.
• Q104058579 description "tieteellinen artikkeli" @default.
• Q104058579 description "tudományos cikk" @default.
• Q104058579 description "vedecký článok" @default.
• Q104058579 description "vetenskaplig artikel" @default.
• Q104058579 description "videnskabelig artikel udgivet 3. december 2020" @default.
• Q104058579 description "vitenskapelig artikkel" @default.
• Q104058579 description "vitskapeleg artikkel" @default.
• Q104058579 description "vědecký článek" @default.
• Q104058579 description "wetenschappelijk artikel" @default.
• Q104058579 description "wissenschaftlicher Artikel" @default.
• Q104058579 description "επιστημονικό άρθρο" @default.
• Q104058579 description "мақолаи илмӣ" @default.
• Q104058579 description "наукова стаття, опублікована в грудні 2020" @default.
• Q104058579 description "научна статия" @default.
• Q104058579 description "научная статья" @default.
• Q104058579 description "научни чланак" @default.
• Q104058579 description "научни чланак" @default.
• Q104058579 description "מאמר מדעי" @default.
• Q104058579 description "مقالة علمية نشرت في 3 ديسمبر 2020" @default.
• Q104058579 description "৩ ডিসেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q104058579 description "บทความทางวิทยาศาสตร์" @default.
• Q104058579 description "სამეცნიერო სტატია" @default.
• Q104058579 name "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 name "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 name "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 type Item @default.
• Q104058579 label "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 label "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 label "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 prefLabel "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 prefLabel "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 prefLabel "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 P1433 Q104058579-1E13520F-4D38-407E-A82E-547AACDAE000 @default.
• Q104058579 P1476 Q104058579-45A87E78-875C-486B-8728-092103D0D5B4 @default.
• Q104058579 P2093 Q104058579-0EE3C769-5DAF-439F-8EE3-D8E07372324E @default.
• Q104058579 P2093 Q104058579-17F5D7F6-9750-4352-AA09-6419215F5139 @default.
• Q104058579 P2093 Q104058579-439084D8-32A3-4A66-8E03-C2E3CBFC8BB5 @default.
• Q104058579 P2093 Q104058579-4BA93A7D-8679-4C2C-8629-A8689B69EC64 @default.
• Q104058579 P2093 Q104058579-67292725-E94D-4DEC-9D30-C846BA13E49B @default.
• Q104058579 P2093 Q104058579-9A355CB5-88C1-4829-8673-52349C74B59F @default.
• Q104058579 P2860 Q104058579-8CBDC45E-37F5-48DD-8F99-A165D68EF426 @default.
• Q104058579 P2860 Q104058579-BF60E188-F27E-4FD9-837D-B8EC3B7E7EE5 @default.
• Q104058579 P2860 Q104058579-C51BC695-1D34-4AED-86F4-F687E9FBA40D @default.
• Q104058579 P31 Q104058579-58E72D0F-A064-4D83-BB46-D091DB97383C @default.
• Q104058579 P356 Q104058579-20066BAE-CB8C-4C69-BD9D-DE8321F83178 @default.
• Q104058579 P50 Q104058579-63DFBEC0-CE1C-4976-AC9A-038F7CD7E63A @default.
• Q104058579 P50 Q104058579-91B704FE-5CBF-467E-B4C2-989F37DBE65F @default.
• Q104058579 P577 Q104058579-A79C2B18-DD8E-4321-BEC6-1F3FF637BB80 @default.
• Q104058579 P5875 Q104058579-4F266246-E9D2-46F9-B68D-695D56419389 @default.
• Q104058579 P698 Q104058579-A0580E76-FD4A-46F4-BF43-44F13B32CD2D @default.
• Q104058579 P356 JCE.14828 @default.
• Q104058579 P698 33270306 @default.
• Q104058579 P1433 Q4736917 @default.
• Q104058579 P1476 "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures" @default.
• Q104058579 P2093 "Andrea Natale" @default.
• Q104058579 P2093 "David DeLurgio" @default.
• Q104058579 P2093 "G Joseph Gallinghouse" @default.
• Q104058579 P2093 "J David Burkhardt" @default.
• Q104058579 P2093 "Mark W Preminger" @default.
• Q104058579 P2093 "Rodney P Horton" @default.
• Q104058579 P2860 Q35781620 @default.
• Q104058579 P2860 Q36976337 @default.
• Q104058579 P2860 Q37381443 @default.

• next